[Clinical efficacy of combined therapy with verapamil and fast sodium channel blockers for refractory atrial fibrillation].
A total of 70 patients aged 38-73 years who suffered from various circulatory disorders and refractory atrial fibrillation were examined. The majority of patients with refractory atrial fibrillation displayed normalized cardiac rhythm after the combined therapy with verapamil plus one of the fast sodium channel blockers (novocainamide, ethmozine, ethacizine, kinilentin). If the therapy failed, electric cardioversion was applied.
Denisiuk
V I
VI
Lipnitskiĭ
T N
TN
Kotsuta
G I
GI
Stepaniuk
A V
AV
D000328:Adult; D000368:Aged; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D006801:Humans; D008875:Middle Aged; D016293:Moricizine / Q000627:therapeutic use; D010640:Phenothiazines / Q000627:therapeutic use; D011342:Procainamide / Q000627:therapeutic use; D011802:Quinidine / Q000627:therapeutic use; D015222:Sodium Channels / Q000187:drug effects*; D014700:Verapamil / Q000627:therapeutic use*
D000889:Anti-Arrhythmia Agents; D010640:Phenothiazines; D015222:Sodium Channels; D016293:Moricizine; C009764:quinidine bisulfate; D014700:Verapamil; C046818:ethacizine; D011802:Quinidine; D011342:Procainamide
Klinicheskaia éffektivnost' kombinirovannoĭ terapii refrakternoĭ k lecheniiu formy mertsaniia predserdiĭ verapamilom i blokatorami bystrykh natrievykh kanalov.